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Mechanistic Considerations for
Carcinogenic Risk Estimation: Chloroform
by R. H. Reitz,* T. R. Fox* and J. F. Quast*
Chloroform has been reported to induce cancer in rodents after chronic administration ofhigh
doses by gavage. However, the interpretation of these findings is hampered by a lack of
knowledge concerning the relative roles of genetic and nongenetic mechanisms in these
bioassays. The present studies were carried out in male B6C3F1 mice in order to investigate the
potential ofchloroform to induce genetic damage and/or organ toxicity at the sites where tumors
have been observed in the various bioassays. These studies revealed that carcinogenic doses of
chloroform produced severe necrosis at the sites where tumors later developed. This was
demonstrated by light microscopy as well as by determination ofthe cellular regeneration index
following administration of3H-thymidine. Noncarcinogenic doses ofchloroform failed to induce
these responses. In contrast, studies ofDNA alkylation and DNA repair in vivo failed to give any
indication that chloroform had produced the type of genetic alterations associated with known
genotoxic chemicals. These data suggest that the- primary mechanism of chloroform-induced
carcinogenesis is nongenetic in nature. If the same mechanism predominates in man, there
should be little to no carcinogenic risk associated with exposure to noncytotoxic levels of
chloroform.
Introduction
Somechemicalcarcinogensapparentlyactthrough
direct alteration of DNA (by the induction of
somatic mutations). This has led to the speculation
that a single molecular event might influence the
rate of cancer formation. Such a concept does not
allow for the existence of an absolute threshold in
carcinogens acting by this mechanism. However,
considerations such as the multistage nature of
chemical carcinogenesis, the existence of DNA
repairsystemsandimmunesurveilancemechanisms,
and the observation of threshold doses for other
pathological responses support a possible threshold
for at least some carcinogenic agents (1). There has
been, and continues to be, considerable debate on
the subject of thresholds in carcinogenesis.
Consequently, there has been some concern when-
ever large numbers of people are exposed to a
material which has been shown to be an animal
carcinogen, even if the levels of exposure are very
much lower than those employed for the animal
*Toxicology Research Laboratory, Dow Chemical U.S.A.,
1803 Building, Midland, Michigan 48640.
test. Chloroform is one example ofsuch a chemical.
It was tested for possible carcinogenicity following
chronic administration by gavage (2) and found to
induce liver tumors in B6C3F1 mice, as well as
kidney and thyroid tumors in Osborne-Mendel rats.
Human exposures to chloroform are very much
lower than those employed in the gavage bioassay.
The primary source ofexposure is to small amounts
of trihalomethanes (including chloroform) formed
during the chlorination of drinking water supplies.
The Environmental Protection Agency hasrecently
established a maximum contaminant level (MCL)
for chloroform in finished drinking water of 100 ppb
(0.1 mg.). The level chosen by EPA is based on a
risk estimation which suggests that the excess
cancer risk in populations exposed to this level of
chloroform may be as high as 100 cases per million
exposed population (3,4).
The risk estimation cited by the EPA is based
upon the techniques outlined by the National Acad-
emy of Sciences (NAS) (5) in their book, "Drinking
Water and Health." However, there are at least
two reasons why these techniques may not be
appropriate for risk extrapolations with chloro-
form: (1) The NAS indicated that they felt it was
"prudent" to assume, when there was no evidence164
to indicate otherwise, that animal carcinogens were
actingthrough genetic mechanisms and hence could
not be assumed to have any "threshold" in their
activity. This assumption led them to recommend
that mathematical models such as the "one-hit"
model be considered for risk extrapolation. (2) The
NAS also noted that, as a general rule, processes
such as metabolism and excretion occur less rapidly
in man than in laboratory rodents (6). Since these
processes are often involved in detoxification of
foreign chemicals, the NAS also suggested that,
when there was no evidence to indicate otherwise,
man should be considered to be more sensitive to
the toxicity (including carcinogenicity) of foreign
chemicals than rodents.
However, there is reason to believe that neither
of these assumptions are justified when the carci-
nogenic risk associated with exposure to low levels
of chloroform is estimated. Pertinent data for a
more realistic estimation ofcarcinogenicriskwillbe
discussed below.
Methods
Animals
Male mice (CD-1 or B6C3F1 strains) and male
rats (Sprague-Dawley strain) were obtained from
Charles River Laboratories, Wilmington, Mass. All
animals were acclimated for atleast one weekbefore
use.
Materials
"4C-Chloroform was obtained from New England
Nuclear (Catalog No. NEC-351) with a reported
specific activity of5.4 mCi/mmole and aradiochemi-
cal purity of > 97%. Nonradioactive chloroform
was Baker Analytical Reagent grade containing
0.7% ethanol as a preservative (and less than
0.1% of any other materials). All other materials
were reagent grade from commercial supply
houses.
Enzymes used in the purification of DNA
a-amylase, typsin, chymotrypsin, ribonuclease-A,
and deoxyribonuclease (DN-100) were obtained
from Sigma Chemical Co., St. Louis, Mo.
DNA Alkylation
Thepotentialofchloroformto cause DNAalkylation
in vivo was estimated by measuring the specific
radioactivityofDNAisolatedfromanimals sacrificed
4 hr after exposure to 14C-chloroform (240 mg/kg,
PO). DNA was isolated from the livers and kidneys
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of these animals by the method of Marmur (7) as
modified by Reitz et al. (8).
The modified procedure involved the precipita-
tion ofisolated DNA from solution with 5% trichloro-
acetic acid (TCA), hydrolysis ofthe precipitate in a
buffered solutionofpurified deoxyribonuclease, and
reprecipitation of insoluble impurities by addition
of more TCA (final concentration 5%). Following
the second precipitation, the incubation is filtered
through a Millipore filter (5 ,um pore size) and the
filtrate is collected. This last step removes many
contaminatingmacromolecules suchasprotein, RNA,
and glycogen.
These conditions are similar to those employed
by others (9-11). The mild acid and enzyme treat-
ments would not be expected to degrade cova-
lently bonded DNA adducts, and levels of DNA
alkylation obtained using these methods are consis-
tent with those reported by other investigators
(12).
DNA Repair in Vivo
DNA repair was estimated by administeringnon-
radioactive chloroform to animals and subsequently
determiningtherateofincorporationof3H-thymidine
into DNA in animals receiving doses of hydroxy-
urea sufficient to depress normal DNA synthesis.
Details of this procedure have been described pre-
viously (8).
Other Analyses
Glycogen, RNA, and protein in the final DNA
preparation were determined by the methods of
Shields and Burnett (13), Brown (14), and Bradford
(15), respectively. Radioactivity was determined
byliquid scintillation countingwith automatic quench
correction (Beckmann LS-9000). DNA concentra-
tion was estimated by the method of Burton (16).
Cellular Regeneration
Male mice were gavaged with various doses of
unlabeledchloroform, heldfor4hr, andtheninjected
IP with 3H-thymidine. Four hours later, these ani-
mals were sacrificed, and DNA was isolated from
liver and kidney samples as outlined by Reitz et al.
(8). The cellular regeneration index was estimated
by determining the relative specific radioactivity in
the DNA from treated and control groups.
Histopathological Assessment
Samples of kidney and liver were removed at
necropsy and fixed in buffered 10% formalin. TheRISK ESTIMATION FOR CHLOROFORM
tissues were processed by routine histologic proce-
dures. Sections (5-6 ,um) were stained with hema-
toxylin and eosin and examined by light microsco-
PY.
Statistical Analyses
Datawere analyzedbytheprocedure ofWilcoxon
(17) as modified by Mann and Whitney (18) for
unequal sample sizes. Outliers were removed as
outlined by Grubb (19) before analysis. The level of
significance was chosen to be p < 0.05.
Results
DNA Alkylation
Thelevels ofradioactivityincorporatedinto DNA
isolated from the liver and kidney of B6C3F1 mice
exposed to '4C-chloroform are summarized in Table
1. These data are reported as micromole equiva-
lents of chloroform bound per mole of DNA phos-
phorus, adjustedtoanequivalentdoseof1mmole/kg.
The levels of radioactivity in the DNA isolated
from the organs of the chloroform-treated mice
represented about 10 to 20 dpm over background
counts in samples of DNA isolated from untreated
mice. (All samples were counted for 100 min in
order to accumulate sufficient counts for accurate
estimation ofthe low amounts ofradioactivity pres-
ent.) It must be emphasized that the radioactivity
observed in the DNA may also arise from biosyn-
thetic incorporation ofradioactive one carbon frag-
ments during normal DNA synthesis. Hence the
value reported must be considered an "upper limit"
Table 1. Chemical binding indexes (CBI) for binding of
various chemicals to DNA in vivo at a standard dose of 1
mmole/kg according to Lutz (26).
Chemical,
Potency rating ,umole/mole DNA
Strong
Aflatoxin 17,000a
Dimethylnitrosamine 6,000a
Dimethylnitrosamine 7,430b
Moderate
2-Acetylaminofluorene 560a
O-Aminoazotoluene 230a
Weak
Urethane 29-90a
4-Dimethylaminoazobenzene 6a
Experimental results for selected chernicals
Chloroform 1.5 (Det. Limit= 1)b
Perchloroethylene 0.0 (Det. Limit=10)b
aData from Lutz (26).
bData gathered in Dow Laboratories.
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rather than an accurate estimate of the level of
DNA alkylation.
DNA Repair
Repair of DNA (estimated as hydroxyurea-
resistant incorporation of3H-thymidine into DNA)
also served as anindicatorofthe potential ofchloro-
formto causegenetic effects. Intraperitoneal admini-
strationofdimethylnitrosamine (DMN)causedlarge
increases in DNA repair in the liver of B6C3F1
mice (Fig. 1), but chloroform (240 mg/kg, PO) was
inactive in this system. Thus these data also fail to
indicate any significant genotoxic activity for orally
administered chloroform in mice.
Cellular Regeneration
Cellular regeneration was increased 14-fold in
theliverofmale micetreated with240mg/kg(Table
2). Much smaller effects on cellular regeneration in
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FIGURE 1. DNA repair in the liver of mice treated with
dimethylnitrosamine (DMN) or chloroform (CHCla) relative
to control groups.166
Table 2. Cellularregeneration (estimated bydetermination of
relative incorporation of 3H-thymidine into DNA) in tissues
ofmale B6C3F1 mice ormaleOsborne-Mendel rats48 hrafter
a single gavage dose of chloroform.
Tissue/dose DPM/g DNA ± SD Ratio
Liver (mice)
Control 3.6 ± 1.5 (n = 5)
15 mg/kg 3.4 ± 2.2 (n = 5) 0.94
60 mg/kg 8.0 ± 3.3 (n = 6) 2.2
240 mg/kg 50.6 ± 13.0 (n = 6) 14.Oa
Kidney (mice)
Control 2.4 ± 0.21 (n = 5)
15 mg/kg 1.9 ± 0.32 (n = 5) 0.79
60 mg/kg 19.6 ± 16.2 (n = 6) 8.2a
240 mg/kg 59.4 ± 10.6 (n = 6) 24.8a
Liver (rats)
180 mg/kg 2.6b
Kidney (rats)
180 mg/kg 1.4b
aSignificantly different from control (p < 0.05, Mann Whitney
U test).
bData from Reitz et al. (20).
the liver were observed in the groups receiving
either 60 mg/kg (2.2-fold increase) or 15 mg/kg.
The kidney tissue of mice was more sensitive
than the liver tissue to the effects of chloroform.
Cellular regeneration was increased 25-fold in the
kidneys of mice receiving 240 mg/kg, and 8-fold in
mice receiving 60 mg/kg. No effects on cellular
regeneration were seen in the kidneys of mice
receiving 15 mg/kg ofchloroform by gavage (Table
2).
In order to further characterize the effects of
chloroform on liver and kidney tissue, small groups
ofmice (two/dose) were gavaged with various doses
of chloroform and then sacrificed 48 hr later for
examination by histopathological techniques. Tis-
sue damage was readily observable in the tissues
where cellular regeneration had been stimulated
(Table 3). Damage was severe enough to bejudged
necrotic following 240 mg/kg in both liver and kid-
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ney, whiletubularepithelialregeneration wasnoted
in the corticomedulary region ofkidneys from mice
gavaged with 60 mg/kg. No microscopic changes
were observed in liver or kidney tissue obtained
from mice gavaged with 15 mg/kg of chloroform
(Table 3).
Previous experiments indicated that rats were
less sensitive than mice to the toxic effects of
chloroform, including the production of increased
cellular regeneration. Male Osborne-Mendel rats
dosed with 180 mg/kg ofchloroform showed a 160%
increase in cellular regeneration in the liver, and a
40% increase in the kidney (20) (Table 2).
Discussion
Chloroform has been tested in several of the
standard tests designed to detect mutagenic (and
hencepresumablycarcinogenic)potential. Theresults
have been generally negative. For instance, two
groups reported that chloroform failed to induce
mutations in Salmonella typhimurium (21,22), and
chloroform was also negative in a sex-linked reces-
sivelethaltestconductedinDrosophilamelanogaster
(23). Most recently, chloroform was selected as one
ofseveral prototype chemicals to be evaluated in a
comprehensive battery of short term tests for car-
cinogenicity. The results of these tests were sum-
marized by Bridges et al. (24) and Brooks and
Preston (25). Chloroform was consistently negative
in tests for genotoxicity (24, 25).
The results of these studies of DNA alkylation
and DNA repair are also inconsistent with the
theory that chloroform can induce somatic muta-
tions ofthe type that may lead to cancer. Doses of
chloroform which exceeded those known to produce
liver cancer in mice produced orders of magnitude
less DNAalkylationthanthatobserved withknown
genotoxic agents (Table 1). For comparative pur-
poses, the degrees of alkylation of DNA produced
in the target organs by known genotoxic chemicals
(utilizing the same routes of administration known
Table 3. Histopathology in tissues of male B6C3F1 mice 48 hr after exposure to single oral doses of chloroform.
No. mice affected/no. mice examined
after various doses of chloroform
Microscopic observation 0 15 mg/kg 0 mg/kg 240 mg/kg
Liver
Individual hepatocellular necrosis; inflammatory cell infiltration 0/2 0/2 0/2 2/2
Increased mitosis 0/2 0/2 0/2 2/2
Centrilobular hepatocellular swelling (2/3 lobule involved) 0/2 0/2 0/2 2/2
Kidney
No microscopic change 2/2 2/2 0/2 0/2
Severe diffuse renal cortical necrosis 0/2 0/2 0/2 2/2
Focal tubular epithelial regeneration; corticomedullary junction 0/2 0/2 2/2 2/2RISK ESTIMATION FOR CHLOROFORM
to produce tumors) are summarized in Table 1.
These data are from the publication of Lutz (26),
and are all reported as micromoles of chemical
bound per mole of DNA at a standard dose of 1
mmole/kg. Lutz observed a reasonable correlation
between the in vivo potency for DNA alkylation
and the potency as carcinogens (26) and proposed
this method as a useful tool for estimating relative
carcinogenic hazard.
Although it is not clear which sites of DNA are
most sensitive to potentially mutagenic effects, or
whether the various sites are equally susceptible to
in vivo DNA repair mechanisms, the very low
aklylationofDNAobserved afterchloroformadmini-
stration suggests that the genotoxic potential of
chloroform is minimal.
Furthermore, the failure ofchloroform to stimu-
late any detectable activity in the DNA repair
systems (Fig. 1) also suggests that no biologically
significant alteration of DNA has occurred, even
following administration ofa dose which was carci-
nogenic in the NCI bioassay.
In contrast, severe tissue damage was produced
in mice in the organs where tumors were reported
to develop in two bioassays of chloroform (2,27).
This damage was clearly visible at necropsy in the
kidneys and livers of mice treated with high doses
of chloroform.
This damage was also sufficient to stimulate cel-
lular regeneration at these sites (Table 2). Both
cellular regeneration and tissue damage were well
correlated with the tumorigenicity in mice. For
example, doses of 60 and 240 mg/kg stimulated
cellulargeneration inthe kidney, and Roe et al. (27)
reported that 60 mg/kg induced kidney tumors in
one offour strains ofmale mice. 15 mg/kg ofchloro-
form failed to induce cellular regeneration and also
was inactive (at any site) in the bioassay of Roe et
al. The liver ofmale mice was less sensitive to the
administration ofchloroform. Cellular regeneration
was not stimulated greatly at doses of chloroform
below 240 mg/kg (Table 2), and liver tumors were
only observed in mice after administration ofdoses
above 100 mg/kg (2).
The presence of toxicity sufficient to produce
necrosis (with attendant cellular regeneration)
throughout the lifetime of the animal is a very
significant observation, because it is well known
that rapidly dividing cells are more sensitive to
mutagenic stimuli than are quiescent cells (28,29).
Increased cellular regeneration has been correlated
with the tumorigenicity of other materials such as
vinylidene chloride (8) and perchloroethylene (30).
Increased cellularregeneration apparentlypreceded
tumor development in every case in the bioassays
ofchloroform in mice.
The role of cellular regeneration in the chloro-
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form bioassays in rats is not as clear. The NCI did
not observe treatment-related tumors of the liver
in Osborne-Mendel rats, and this is consistent with
amuch lower stimulation ofcellular regeneration in
the liver of rats following gavage with chloroform
(20) as well as the report ofBull et al. (31) that the
fatty infiltration of liver observed in B6C3F1 mice
consuming drinking water with high levels of chlo-
roform was not detected in Osborne-Mendel rats
under similar conditions.
However, cellular regeneration was not greatly
stimulated in the kidney of rats following acute
treatment with 180 mg/kg chloroform (20), and this
is a site where tumors did develop in the NCI
bioassay. Clearly the effects of chronic chloroform
treatment on the kidney of rats need to be better
characterized.
Nevertheless, mice appear to be clearly more
sensitive to the toxic effects of chloroform, includ-
ing carcinogenicity, than rats. As discussed else-
where (32), the toxicity ofchloroform is apparently
due to the production of a reactive metabolite pro-
duced by mixed function oxidases from the rela-
tively inert chloroform molecule. Chloroform thus
appears to belong to a class of chemicals which
require metabolic activation for toxicity. Consequent-
ly, any species variation in the capacity to metabo-
lize chloroform should dramatically affect the onco-
genicity of this compound.
Mice have a much higher rate of oxidation of
halogenatedhydrocarbons toreactiveintermediates
than rats, and most of the halogenated hydrocar-
bons which produce tumors are more active in mice
than rats. Since the relative activity of similar
enzymes in manis less than eitherofthe two rodent
species (5,6) these considerations suggest that man
should be less sensitive than either rodent species
to any tumorigenic activity of chloroform.
ChangandPeriera(33)havestudiedthealkylation
of hemoglobin by 14C-chloroform in rats and mice,
and they found that, in contrast to cytotoxicity and
carcinogenicity, the levels of alkylation were very
similar in the two species. The reason for this
discrepancy is not clear, but it may be that the rate
of bioactivation (relative to the rate of detoxifica-
tion through some pathway such as glutathione
conjugation) is more critical than the total amount
of metabolite formed.
In summary, chloroform failed to demonstrate
genotoxic potential in the followingbattery oftests:
bacterial mutagenicity; mammalian cellmutagenici-
ty; dominant lethal tests in D. melanogaster; DNA
alkylation in vivo; DNA repair in vivo.
However, the carcinogenicity ofchloroform, par-
ticularly in mice, did appear to be correlated with
theproductionofrecurrentcytotoxicity. Whensuch
cytotoxicity is produced through the lifetime of an168 REITZ, FOX AND QUAST
animal, increased frequencies and/or shorter laten-
cies of spontaneous tumors may be expected.
These considerations provide a firm basis for
discarding procedures such as the "one-hit" model
for risk estimation, since these assume a genotoxic
component. Increased tumor frequencies would not
be expected from exposure to levels of chloroform
below the cytotoxic threshold, since the genotoxic
potential of chloroform appears to be nil.
This work was presented orally in part at the 3rd Conference
on Water Chlorination, Colorado Springs, Colo., November 1,
1979. In addition, a portion ofthis material was presented orally
to the Toxicology Forum, Aspen, Colo., July 26, 1980.
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